JW (Cayman) Therapeutics Co. Ltd. (2126)
Market Closed
10 Aug, 08:00
HKEX HKEX Primary 
OTC PINK 1. 87
HKD +0.08
+4.4693%
1.3B Market Cap
- P/E Ratio
- Div Yield
1.89M Volume
0 Eps
1.79 HKD
Previous Close Want to track 2126 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
JW (Cayman) Therapeutics Co. Ltd. (2126) Statistics
Valuation metrics
Market Cap 1.3B
Enterprise value 399.46M
Trailing P/E (ttm) -1.16
Forward P/E -
PEG ratio -0.17
Price/Sales (ttm) 2.28
Price/Book (mrq) 1.15
Enterprise Value/Revenue 1.42
Enterprise Value/EBITDA -1.83
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 781.25K
Average volume (90 days) 697.05K
Price summary
52-Week low 1.4
52-Week high 6.35
Beta -
50-Day moving average 1.68
200-Day moving average 2.04
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.96%
Operating margin -1.05%
Operational effectiveness
Return on assets -0.56%
Return on equity -0.75%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.67
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.32
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.21
Total debt (mrq) -
Total Debt/Equity (mrq) 0.47
Current ratio (mrq) 1.45%
Book value per share (mrq) 1.34
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
